-
Something wrong with this record ?
Prague hereditary hypercholesterolemic (PHHC) rat - a model of polygenic hypercholesterolemia
J. Kovář, Z. Tonar, M. Heczková, R. Poledne
Language English Country Czech Republic
Document type Review
Grant support
NR9401
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Atherosclerosis genetics metabolism pathology MeSH
- Cholesterol, Dietary adverse effects MeSH
- Cholesterol blood MeSH
- Phenotype MeSH
- Financing, Organized MeSH
- Genetic Predisposition to Disease MeSH
- Hybridization, Genetic MeSH
- Hypercholesterolemia genetics blood pathology MeSH
- Liver metabolism pathology MeSH
- Rats MeSH
- Lipoproteins blood MeSH
- Disease Models, Animal MeSH
- Multifactorial Inheritance MeSH
- Rats, Wistar MeSH
- Disease Progression MeSH
- Fatty Liver genetics metabolism pathology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Review MeSH
Prague hereditary hypercholesterolemic (PHHC) rat - rat strain crossbred from Wistar rats - is a model of hypercholesterolemia induced by dietary cholesterol. Importantly, no bile salts and/or antithyroid drugs need to be added to the diet together with cholesterol to induce hypercholesterolemia. PHHC rats have only modestly increased cholesterolemia when fed a standard chow and develop hypercholesterolemia exceeding 5 mmol/l on 2 % cholesterol diet. Most of the cholesterol in hypercholesterolemic PHHC rats is found in VLDL that become enriched with cholesterol (VLDL-C/VLDL-TG ratio > 1.0). Concurrently, both IDL and LDL concentrations rise without any increase in HDL. PHHC rats do not markedly differ from Wistar rats in the activities of enzymes involved in intravascular remodelation of lipoproteins (lipoprotein and hepatic lipases and lecithin:cholesterol acyltransferase), LDL catabolism, cholesterol turnover rate and absorption of dietary cholesterol. The feeding rats with cholesterol diet results in development of fatty liver in spite of suppression of cholesterol synthesis. However, even though cholesterolemia in PHHC rats is comparable to human hypercholesterolemia, the PHHC rats do not develop atherosclerosis even after 6 months on 2 % cholesterol diet. Importantly, the crossbreeding experiments documented that hypercholesterolemia of PHHC rats is polygenic. To identify the genes that may be involved in pathogenesis of hypercholesterolemia in this strain, the studies of microarray gene expression in the liver of PHHC rats are currently in progress.
References provided by Crossref.org
Lit.: 13
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10013420
- 003
- CZ-PrNML
- 005
- 20151006141208.0
- 008
- 100604s2009 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931916 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kovář, Jan, $d 1952- $7 jn20040114001
- 245 10
- $a Prague hereditary hypercholesterolemic (PHHC) rat - a model of polygenic hypercholesterolemia / $c J. Kovář, Z. Tonar, M. Heczková, R. Poledne
- 314 __
- $a Center for Cardiovascular Research, Prague jan.kovar@medicon.cz
- 504 __
- $a Lit.: 13
- 520 9_
- $a Prague hereditary hypercholesterolemic (PHHC) rat - rat strain crossbred from Wistar rats - is a model of hypercholesterolemia induced by dietary cholesterol. Importantly, no bile salts and/or antithyroid drugs need to be added to the diet together with cholesterol to induce hypercholesterolemia. PHHC rats have only modestly increased cholesterolemia when fed a standard chow and develop hypercholesterolemia exceeding 5 mmol/l on 2 % cholesterol diet. Most of the cholesterol in hypercholesterolemic PHHC rats is found in VLDL that become enriched with cholesterol (VLDL-C/VLDL-TG ratio > 1.0). Concurrently, both IDL and LDL concentrations rise without any increase in HDL. PHHC rats do not markedly differ from Wistar rats in the activities of enzymes involved in intravascular remodelation of lipoproteins (lipoprotein and hepatic lipases and lecithin:cholesterol acyltransferase), LDL catabolism, cholesterol turnover rate and absorption of dietary cholesterol. The feeding rats with cholesterol diet results in development of fatty liver in spite of suppression of cholesterol synthesis. However, even though cholesterolemia in PHHC rats is comparable to human hypercholesterolemia, the PHHC rats do not develop atherosclerosis even after 6 months on 2 % cholesterol diet. Importantly, the crossbreeding experiments documented that hypercholesterolemia of PHHC rats is polygenic. To identify the genes that may be involved in pathogenesis of hypercholesterolemia in this strain, the studies of microarray gene expression in the liver of PHHC rats are currently in progress.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ateroskleróza $x genetika $x metabolismus $x patologie $7 D050197
- 650 _2
- $a cholesterol $x krev $7 D002784
- 650 _2
- $a cholesterol dietní $x škodlivé účinky $7 D002791
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ztučnělá játra $x genetika $x metabolismus $x patologie $7 D005234
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a hybridizace genetická $7 D006824
- 650 _2
- $a hypercholesterolemie $x genetika $x krev $x patologie $7 D006937
- 650 _2
- $a lipoproteiny $x krev $7 D008074
- 650 _2
- $a játra $x metabolismus $x patologie $7 D008099
- 650 _2
- $a multifaktoriální dědičnost $7 D020412
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Tonar, Zbyněk, $d 1976- $7 xx0074224
- 700 1_
- $a Heczková, Marie $7 xx0102189
- 700 1_
- $a Poledne, Rudolf, $d 1940- $7 nlk20040147088
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 58,Suppl. 2 (2009), s. S95 - S99 $x 0862-8408
- 773 0_
- $t Center for cardiovascular research $g Roč. 58,Suppl. 2 (2009), s. S95 - S99 $w MED00173857
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/58%20Suppl%202/58_S95.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 8 $z 0
- 990 __
- $a 20100603155515 $b ABA008
- 991 __
- $a 20151006141353 $b ABA008
- 999 __
- $a ok $b bmc $g 749282 $s 612923
- BAS __
- $a 3
- BMC __
- $a 2009 $b 58 $c Suppl. 2 $d S95 - S99 $m Physiological research $x MED00003824
- BMC __
- $a 2009 $b 58 $c Suppl. 2 $d S95 - S99 $m Center for cardiovascular research $x MED00173857
- GRA __
- $a NR9401 $p MZ0
- LZP __
- $a 2010-15/mkme